Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Interest Expenses: 2009-2013

Historic Interest Expenses for Ani Pharmaceuticals (ANIP) over the last 5 years, with Dec 2013 value amounting to $467,000.

  • Ani Pharmaceuticals' Interest Expenses fell 99.89% to $98 in Q4 2013 from the same period last year, while for Dec 2013 it was $555,437, marking a year-over-year decrease of 30.07%. This contributed to the annual value of $467,000 for FY2013, which is 64.81% down from last year.
  • According to the latest figures from FY2013, Ani Pharmaceuticals' Interest Expenses is $467,000, which was down 64.81% from $1.3 million recorded in FY2012.
  • Over the past 5 years, Ani Pharmaceuticals' Interest Expenses peaked at $1.3 million during FY2012, and registered a low of $147,025 during FY2009.
  • In the last 3 years, Ani Pharmaceuticals' Interest Expenses had a median value of $681,573 in 2011 and averaged $825,191.
  • Its Interest Expenses has fluctuated over the past 5 years, first spiked by 368.00% in 2010, then crashed by 64.81% in 2013.
  • Yearly analysis of 5 years shows Ani Pharmaceuticals' Interest Expenses stood at $147,025 in 2009, then surged by 368.00% to $688,083 in 2010, then dropped by 0.95% to $681,573 in 2011, then soared by 94.70% to $1.3 million in 2012, then plummeted by 64.81% to $467,000 in 2013.